Cowen Group is a diversified financial services firm providing alternative investment management, investment banking, research, and sales and trading services through its business units, Ramius and Cowen and Company. Its alternative investment manage...Show all
Phone: 646-562-1000
599 Lexington Avenue
19th Floor
New York, 10022
New York, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2017-12-20 | Orchard Therapeutics | Series B | $110M | 4BIO Capital, Agent Capital, Baillie Gifford & Co., F-Prime Capital, Juda Capital, Pavilion Capital International, RTW Investments, Temasek Holdings, and UCL Technology Fund |
| 2017-11-30 | Semma Therapeutics | Series B | $114M | ARCH Venture Partners, Eight Roads Ventures, F-Prime Capital, JDRF T1D Fund, Medtronic, MPM Capital, and Novartis |
| 2017-07-25 | Kezar Life Sciences | Series B | $50M | AJU IB Investment, Bay City Capital, Cormorant Asset Management, EcoR1 Capital, Morningside Ventures, Omega Fund Management, Pappas Ventures, and Qiming Venture Partners |
| 2017-04-03 | Convergex Group | Acquired | ||
| 2017-01-12 | Linkem | Corporate Minority | $106.3M | BlackRock, and Jefferies Financial Group |
